Zai Lab
ZLAB
25.31
-0.27
-1.06%
Zai Lab
US · ZLAB
#2554 by market cap
Listed 2017
25.31
-0.27
-1.06%
Live - 5344 symbols - heartbeat 7s ago
· 2026-10-08 08:16
Pre-market
24.54
-3.04%
After-hours
24.80
-2.02%
Overnight
24.55
-3.00%
- Market cap
- 2.84B
- P/E (TTM)i
- -14.89
- P/Bi
- 4.68
- EPSi
- -1.60
- Div yieldi
- 0.00%
- 52W posi
- 59%
Reader sentiment
Are you bullish or bearish on ZLAB?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
U.S. Stocks Move | Zai Lab (ZLAB.US) Surges Over 12% as Q2 Product Revenue Rises 11% SequentiallyZhitong Finance · 2026/8/6
-
Rating change
Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $37Market Newswire · 2026/2/27
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $53Market Newswire · 2026/2/23
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/8/7
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $27Market Newswire · 2026/5/23
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Announces Target Price $39Market Newswire · 2026/2/5
-
US Stock Movement | Shares Surge for Two Consecutive Days! Zai Lab (ZLAB.US) Rises Over 10%Zhitong Finance · 2026/8/7
-
Rating change
Cantor Fitzgerald Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $37Market Newswire · 2026/8/7
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $47Market Newswire · 2026/2/27
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy RatingMarket Newswire · 2026/4/21
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $44Market Newswire · 2026/5/8
-
J.P. Morgan Keeps Their Buy Rating on Zai Lab (ZLAB)TipRanks · 2026/9/2
-
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/9/2
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $47Market Newswire · 2026/3/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Maze Therapeutics, Inc. (MAZE) and Compass Therapeutics (CMPX)TipRanks · 2026/3/26
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/3/26
-
Rating change
BofA Securities Maintains Zai Lab(ZLAB.US) With Hold Rating, Cuts Target Price to $21.8Market Newswire · 2026/2/27
-
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/8/27
-
Rating change
J.P. Morgan Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $32Market Newswire · 2026/3/18
-
Rating change
Citi Maintains Zai Lab(ZLAB.US) With Buy Rating, Cuts Target Price to $53Market Newswire · 2026/2/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 08:16:37 · For reference only, not investment advice and not tailored to your situation.